Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphoma.
Duarte BK, Valente I, Vigorito AC, Aranha FJ, Oliveira-Duarte G, Miranda EC, Lorand-Metze I, Pagnano KB, Delamain M, Marques Junior JF, Brandalise SR, Nucci M, De Souza CA. Duarte BK, et al. Clin Lymphoma Myeloma. 2009 Dec;9(6):449-54. doi: 10.3816/CLM.2009.n.088. Clin Lymphoma Myeloma. 2009. PMID: 19951885
Orbital lymphoma mimicking ophthalmopathy in a patient with Graves'.
Moura Neto A, Denardi FC, Delamain MT, Tambascia MA, Vassallo J, Caldato R, Zantut-Wittmann DE. Moura Neto A, et al. Among authors: delamain mt. Am J Med Sci. 2012 Nov;344(5):418-21. doi: 10.1097/MAJ.0b013e3182582330. Am J Med Sci. 2012. PMID: 22885624
Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas.
Duarte BK, Miranda EC, Nucci M, Vigorito AC, Penteado FJ, Marques JF Jr, Oliveira-Duarte GB, Lorand-Metze IG, Pagnano KB, Delamain MT, Baldissera R, Valente IS, de Souza CA. Duarte BK, et al. Among authors: delamain mt. Rev Bras Hematol Hemoter. 2011;33(6):432-8. doi: 10.5581/1516-8484.20110118. Rev Bras Hematol Hemoter. 2011. PMID: 23049359 Free PMC article.
BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution.
Ribeiro BF, Vergílio BR, Miranda EC, Almeida MH, Delamain MT, da Silveira RA, de Souza CA, Albuquerque DM, Santos AD, Duarte VO, Oliveira-Duarte GB, Lorand-Metze I, Pagnano KB. Ribeiro BF, et al. Among authors: delamain mt. Acta Haematol. 2015;134(4):248-54. doi: 10.1159/000430835. Acta Haematol. 2015. PMID: 26159458 Clinical Trial.
55 results